REVELATION BIOSCIENCES, INC. — All Filings
360 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
25-NSE
3
4
4/A
424B3
424B4
425
5
8-A12B
8-K
8-K/A
CERT
CORRESP
DEF 14A
DEFA14A
DEFR14A
DRS
EFFECT
NT 10-K
NT 10-Q
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-4
S-4/A
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0000950170-22-026866 | Dec 21, 2022 | Dec 19, 2022 |
| PRE 14A | PRELIMINARY PROXY STATEMENT | 0001213900-22-081401 | Dec 20, 2022 | Dec 20, 2023 |
| 8-K | 8-K | 0000950170-22-026382 | Dec 12, 2022 | Dec 6, 2022 |
| S-1 | REGISTRATION STATEMENT | 0001213900-22-075572 | Nov 29, 2022 | — |
| 8-K | CURRENT REPORT | 0001213900-22-075030 | Nov 25, 2022 | Nov 23, 2022 |
| EFFECT | — | 9999999995-22-003347 | Nov 18, 2022 | — |
| CORRESP | — | 0001213900-22-073451 | Nov 17, 2022 | — |
| CORRESP | — | 0001213900-22-073148 | Nov 16, 2022 | — |
| S-1/A | AMENDMENT NO. 1 TO FORM S-1 | 0001213900-22-073146 | Nov 16, 2022 | — |
| UPLOAD | — | 0000000000-22-012322 | Nov 14, 2022 | — |
| 8-K | 8-K | 0000950170-22-024560 | Nov 10, 2022 | — |
| 10-Q | 10-Q | 0000950170-22-024436 | Nov 10, 2022 | Sep 30, 2022 |
| S-1 | REGISTRATION STATEMENT | 0001213900-22-067716 | Oct 31, 2022 | — |
| 8-K | 8-K | 0000950170-22-020014 | Oct 25, 2022 | — |
| 8-K | 8-K | 0000950170-22-019354 | Oct 6, 2022 | — |
| SC 13G/A | AMENDMENT TO FORM SC 13G | 0001683168-22-005877 | Aug 17, 2022 | — |
| 8-K | 8-K | 0000950170-22-017552 | Aug 17, 2022 | Aug 15, 2022 |
| 10-Q | 10-Q | 0000950170-22-017405 | Aug 15, 2022 | Jun 30, 2022 |
| 8-K | 8-K | 0000950170-22-013698 | Aug 1, 2022 | Jul 28, 2022 |
| 424B3 | PROSPECTUS | 0001213900-22-042058 | Jul 27, 2022 | — |
| EFFECT | — | 9999999995-22-002156 | Jul 25, 2022 | — |
| S-1/A | AMENDMENT NO. 3 TO FORM S-1 | 0001213900-22-041331 | Jul 25, 2022 | — |
| CORRESP | — | 0001213900-22-041170 | Jul 25, 2022 | — |
| S-1/A | AMENDMENT NO. 2 TO FORM S-1 | 0001213900-22-040761 | Jul 21, 2022 | — |
| S-1/A | AMENDMENT NO. 1 TO FORM S-1 | 0001213900-22-040064 | Jul 18, 2022 | — |
| UPLOAD | — | 0000000000-22-007547 | Jul 18, 2022 | — |
| S-1 | REGISTRATION STATEMENT | 0001213900-22-038955 | Jul 13, 2022 | — |
| 424B3 | PROSPECTUS | 0001213900-22-035162 | Jun 27, 2022 | — |
| EFFECT | — | 9999999995-22-001764 | Jun 10, 2022 | — |
| 8-K | 8-K | 0000950170-22-011469 | Jun 10, 2022 | Jun 8, 2022 |
| CORRESP | — | 0001213900-22-031550 | Jun 7, 2022 | — |
| UPLOAD | — | 0000000000-22-006093 | Jun 6, 2022 | — |
| S-8 | REGISTRATION STATEMENT | 0001213900-22-030471 | May 31, 2022 | — |
| S-1 | REGISTRATION STATEMENT | 0001213900-22-030462 | May 31, 2022 | — |
| 8-K | 8-K | 0000950170-22-010946 | May 31, 2022 | May 24, 2022 |
| 8-K | 8-K | 0000950170-22-010146 | May 17, 2022 | May 16, 2022 |
| 10-Q | 10-Q | 0000950170-22-009906 | May 16, 2022 | Mar 31, 2022 |
| 8-K | CURRENT REPORT | 0001213900-22-024526 | May 6, 2022 | May 2, 2022 |
| 8-K/A | AMENDMENT NO. 2 TO FORM 8-K | 0001213900-22-021206 | Apr 22, 2022 | Jan 10, 2022 |
| 8-K/A | AMENDMENT NO. 1 TO FORM 8-K | 0001213900-22-020216 | Apr 15, 2022 | Jan 10, 2022 |
| 10-K | ANNUAL REPORT | 0001213900-22-020179 | Apr 15, 2022 | Dec 31, 2021 |
| NT 10-K | NOTIFICATION OF LATE FILING | 0001213900-22-016797 | Mar 31, 2022 | Dec 31, 2021 |
| SC 13G | SC 13G | 0001683168-22-001902 | Mar 24, 2022 | — |
| 8-K | CURRENT REPORT | 0001213900-22-012515 | Mar 15, 2022 | — |
| SC 13G/A | KARPUS INVESTMENT MGT / REVELATION BIOSCIENCES - SCHEDULE 13G/A(#2) | 0001072613-22-000345 | Mar 10, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-22-013741 | Feb 28, 2022 | Feb 25, 2022 |
| SC 13D | SCHEDULE 13D | 0001213900-22-007741 | Feb 15, 2022 | — |
| SC 13G/A | — | 0001076809-22-000110 | Feb 14, 2022 | — |
| SC 13G/A | KARPUS INVESTMENT MGT / REVELATION BIOSCIENCES - SCHEDULE 13G/A(#1) | 0001072613-22-000268 | Feb 14, 2022 | — |
| SC 13G/A | FORM SC 13G/A | 0001062993-22-003699 | Feb 11, 2022 | — |